Xeris Biopharma Holdings (XERS) Goodwill & Intangibles (2021 - 2026)
Xeris Biopharma Holdings' Goodwill & Intangibles was $105.52 million in Q2 2026, down 9.3% from $116.36 million a year earlier and down 2.5% from the prior quarter.
Xeris Biopharma Holdings (XERS) Goodwill & Intangibles (2021 - 2026) Analysis & Trends
At the end of FY2025, Goodwill & Intangibles at Xeris Biopharma Holdings came in at $110.94 million, down 8.9% from FY2024.
- Goodwill & Intangibles has now declined for four consecutive years, with a four-year compound annual growth rate of -7.9% (FY2021 to FY2025).
- In earlier years, Goodwill & Intangibles was $121.78 million in FY2024 (-8.2%), $132.62 million in FY2023 (-7.6%), $143.47 million in FY2022 (-7.0%) and $154.31 million in FY2021.
- The Q2 2026 figure marks the lowest quarterly Goodwill & Intangibles in data going back to Q4 2021.
- Compared with a year earlier, Goodwill & Intangibles has declined for 15 straight quarters, with an average decline of 8.6% over the last eight quarters.
- Over the past five years, the year-over-year decline in Goodwill & Intangibles ranged from 7.0% (Q4 2022) to 9.3% (Q2 2026).
- Per Business Quant data, XERS's Goodwill & Intangibles in the three quarters before Q2 2026 was $108.23 million (Q1 2026), $110.94 million (Q4 2025) and $113.65 million (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Eli Lilly | 1,076.25 Bn | 1,044.84 Bn | 19.71 Bn |
| 2 | Johnson & Johnson | 617.18 Bn | 535.70 Bn | 17.26 Bn |
| 3 | AbbVie | 464.58 Bn | 437.73 Bn | 12.70 Bn |
| 4 | Merck | 356.04 Bn | 310.47 Bn | 12.21 Bn |
| 5 | Novartis Ag | 269.07 Bn | 224.94 Bn | 11.24 Bn |
| 6 | Astrazeneca | 243.21 Bn | 216.77 Bn | 12.86 Bn |
| 7 | Amgen | 217.88 Bn | 173.28 Bn | 7.24 Bn |
| 8 | Gilead Sciences | 179.62 Bn | 153.74 Bn | 6.22 Bn |
| 9 | Pfizer | 158.45 Bn | 105.40 Bn | 10.94 Bn |
| 10 | Xeris Biopharma Holdings | 1.58 Bn | 1.14 Bn | 79.59 Mn |
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 105.52 Mn |
| Mar 31, 2026 | 108.23 Mn |
| Dec 31, 2025 | 110.94 Mn |
| Sep 30, 2025 | 113.65 Mn |
| Jun 30, 2025 | 116.36 Mn |
| Mar 31, 2025 | 119.07 Mn |
| Dec 31, 2024 | 121.78 Mn |
| Sep 30, 2024 | 124.49 Mn |
| Jun 30, 2024 | 127.20 Mn |
| Mar 31, 2024 | 129.91 Mn |
| Dec 31, 2023 | 132.62 Mn |
| Sep 30, 2023 | 135.33 Mn |
| Jun 30, 2023 | 138.05 Mn |
| Mar 31, 2023 | 140.76 Mn |
| Dec 31, 2022 | 143.47 Mn |
| Sep 30, 2022 | 146.18 Mn |
| Jun 30, 2022 | 148.89 Mn |
| Mar 31, 2022 | 151.60 Mn |
| Dec 31, 2021 | 154.31 Mn |
Xeris Biopharma Holdings Goodwill & Intangibles API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=goodwill-and-intangibles&ticker=XERS&period=max&api_key=YOUR_API_KEY
import requests
url = "https://data.businessquant.com/historic"
params = {"slug": "goodwill-and-intangibles", "ticker": "XERS", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()
const res = await fetch("https://data.businessquant.com/historic?slug=goodwill-and-intangibles&ticker=XERS&period=max&api_key=YOUR_API_KEY");
const data = await res.json();